Warning
Mae'r hysbyseb swydd hon wedi dod i ben ac mae'r ceisiadau wedi cau.
Biologics and Medicines Optimisation Pharmacist | Oxford University Hospitals NHS Foundation Trust
| Dyddiad hysbysebu: | 10 Rhagfyr 2024 |
|---|---|
| Cyflog: | Heb ei nodi |
| Gwybodaeth ychwanegol am y cyflog: | £53,755 - £60,504 Per annum pro rata |
| Oriau: | Llawn Amser |
| Dyddiad cau: | 09 Ionawr 2025 |
| Lleoliad: | Oxford, OX3 9DU |
| Cwmni: | Oxford University Hospitals NHS Foundation Trust |
| Math o swydd: | Parhaol |
| Cyfeirnod swydd: | 6815986/321-CSS-6815986-B8a |
Crynodeb
The Medicines Effectiveness Team are excited to announce a fantastic opportunity to join the newly establishedBest Value Medicines and Biologics Team in OUHFT. This innovative team, alongside the Medicines Effectiveness Team, will play a pivotal role in driving cost-saving initiatives across biologic medicines while ensuring that patients continue to receive the highest standards of care.
TheBest Value Medicines and Biologics Teamwill focus on identifying, promoting, and implementing strategies to maximise cost-saving opportunities for both commissioners and the Trust. By evaluating and optimising biologic prescribing and usage, the team will ensure that value for money is achieved across the healthcare system, while maintaining clinical effectiveness and safety.
See Job Description (JD) attached for details.
As a member of this dynamic team, you will work collaboratively with clinical and financial stakeholders, including prescribers, pharmacists, commissioners, homecare and procurement teams, to identify areas where cost efficiencies can be made, particularly in the use of biosimilars and other biologic therapies.
The post holder will play in pivotal role in mobilising identified cost saving initiatives and create a framework for the fast and efficient implementation of cost saving initiatives.
Oxford University Hospitals NHS Foundation Trustis one of the largest NHS teaching trusts in the country. It provides a wide range of general and specialist clinical services and is a base for medical education, training and research. The Trust comprises four hospitals - the John Radcliffe Hospital, Churchill Hospital and Nuffield Orthopaedic Centre in Headington and the Horton General Hospital in Banbury.
Our values, standards and behaviours define the quality of clinical care we offer and the professional relationships we make with our patients, colleagues and the wider community.
We call this Delivering Compassionate Excellence and its focus is on our values of compassion, respect, learning, delivery, improvement and excellence.
These values put patients at the heart of what we do and underpin the quality healthcare we would like for ourselves or a member of our family. Watch how we set out to deliver compassionate excellence via theOUH YouTube channel.
See more details in the attached Job Description (JD).
1 OVERALL OBJECTIVES:
1.1To focus on in the creation of a robust framework to facilitate the early and successful implementation of identified upcoming biosimilars, enabling the Trust to maximize cost efficiencies while maintaining high standards of patient care.
1.2To deputise for the chair of the Best Value Medicines and Biologics Group (BVMB). BVMB will be a subgroup of the Trusts Medicines Management and Therapeutics Committee. Its main function would be to ensure the cost-effective use of biologic medicines and to coordinate the savings plan on biologics and other high-cost medicines, especially biosimilars and other high-cost medicines that have their patient expired.
1.3To support the Biologics and Medicine Value Lead pharmacists by promoting and facilitating best value in the use of HCD with a particular focus on biologic medicines (including biosimilars) ensuring best value, reduced harm and improved outcomes from the significant investment in medicines.
1.4To play a key role in implementing savings initiatives relating to biologics, for example, introducing new biosimilar products into the Trust.
1.5To identify savings opportunities relating to biologic medicines and implement a program of projects to achieve the savings. The Senior Pharmacy Management Team, The Medicines Effectiveness Team, NHSE Specialised Commissioning Pharmacy Team and BOB ICB Medicines Optimisation Team will support this.
1.6To work as part of the Trust’s Best Value Medicines and Biologics and Medicines Effectiveness teams to achieve the Trust's Medicines Optimisation strategy in relation to the clinical and cost-effective use of medicines within the Trust.
1.7To work with the OUH Medicines homecare team to optimise the use of homecare for biologics and other high-cost medicines.
1.8To work collaboratively alongside Commissioning Pharmacists to deliver the best value from the use of HCDs by supporting cost saving initiatives.
1.12 To attend and/or provide information for appropriate prescribing committee meetings such as the Trust’s Medicines Management Therapeutics Committee (MMTC), Cost Effective Use of Medicines Group, Homecare User Group, as well as BOB ICB’s High-Cost Drugs Group, NHSE High-Cost Drugs, Medicines Optimisation Collaborative Leadership Group (MOCL), as well as other OUH and stakeholder meetings as needed.
This advert closes on Sunday 29 Dec 2024
Aelod balch o'r cynllun cyflogwyr Hyderus o ran Anabledd
Hyderus o ran Anabledd
Gwybodaeth am Hyderus o ran Anabledd
Yn gyffredinol, bydd cyflogwr Hyderus o ran Anabledd yn cynnig cyfweliad i unrhyw ymgeisydd sy'n datgan eu bod yn anabl ac yn bodloni'r meini prawf lleiaf ar gyfer y swydd fel y diffinnir gan y cyflogwr. Mae'n bwysig nodi, mewn rhai sefyllfaoedd recriwtio fel nifer fawr o ymgeiswyr, cyfnod tymhorol ac amseroedd prysur iawn, efallai y bydd y cyflogwr am gyfyngu ar y niferoedd cyffredinol o gyfweliadau a gynigir i bobl anabl a phobl nad ydynt yn anabl. Am fwy o fanylion ewch i Hyderus o ran Anabledd.